Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 5/20 | 0.35 |
| ▸ | CES1 | P23141 | 5/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | EIF4A3 | P38919 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29009857 | 0.81 | PDE2A (0.38) | — | |
| SCHEMBL29009822 | 0.80 | CES2 (0.38) | SLC1A3SLC1A2SLC1A1CES2CES1 | |
| SCHEMBL6902621 | 0.79 | SRC (0.36) | SLC1A3SLC1A2SLC1A1CES2CES1 | |
| SCHEMBL3065996 | 0.78 | CES2 (0.53) | CES2CES1CA1CA2 | |
| SCHEMBL16681214 | 0.78 | CES2 (0.53) | CES2CES1 | |
| SCHEMBL5085546 | 0.77 | CES2 (0.39) | SLC1A3SLC1A2SLC1A1CES2CES1 | |
| SCHEMBL5085545 | 0.77 | CES2 (0.39) | SLC1A3SLC1A2SLC1A1CES2CES1 | |
| SCHEMBL29653910 | 0.77 | CES2 (0.39) | SLC1A3SLC1A2SLC1A1CES2CES1 | |
| SCHEMBL27876501 | 0.77 | — | — | |
| SCHEMBL7465838 | 0.76 | PTGS1 (0.33) | SLC1A3SLC1A2SLC1A1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116209433-A | Small molecule albumin binding agents | 俄勒冈健康科学大学 | 2023-06-02 | — | — | CN | disclosed |